Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps

Benzinga

2024-12-17

Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.

As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.

The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.

Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.

This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.

This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.

Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.

Price Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.

Read Next:

Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept

Image via Shutterstock.

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

ROCKWELL MEDICAL (RMTI): Free Stock Analysis Report

This article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492962603"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492962603\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2492962603?lang=zh_CN&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/mCqFj4XahOwNwGjJizxT4w--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b","is_english":true,"pubTime":"2024-12-17 20:51","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2492962603","market":"us","top_or_hot":-1,"title":"Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps","media":"Benzinga","content":"<html><body><img height=\"675\" src=\"https://s.yimg.com/uu/api/res/1.2/K0GrINPdES.HdePBstby0g--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b\" width=\"1200\"/>\n<p><strong><a href=\"https://laohu8.com/S/RMTI\">Rockwell Medical</a>, Inc.</strong> (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.</p>\n<p>As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.</p>\n<p>The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.</p>\n<p>Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.</p>\n<p>This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.</p>\n<p>This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.</p>\n<p>Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.</p>\n<p><strong>Price Action</strong>: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.</p>\n<p><strong>Read Next</strong>:</p>\n<ul>\n<li><strong>Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept</strong></li>\n</ul>\n<p><em>Image via Shutterstock.</em></p>\n<p>Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. <strong>Click now to access unique insights</strong> that can set you ahead in today's competitive market.</p>\n<p>Get the latest stock analysis from Benzinga?</p>\n<ul>\n<li>ROCKWELL MEDICAL (RMTI): Free Stock Analysis Report</li>\n</ul>\n<p>This article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com</p>\n<p><i>© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 20:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/rockwell-medical-scores-multi-dialysis-125116099.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.\nAs per the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/rockwell-medical-scores-multi-dialysis-125116099.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://finance.yahoo.com/news/rockwell-medical-scores-multi-dialysis-125116099.html","article_id":"2492962603","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/mCqFj4XahOwNwGjJizxT4w--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492962603","pubTimestamp":1734439876,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Rockwell Medical, Inc.  shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.Also, last mon","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","RMTI":"Rockwell Medical"},"translate_title":"罗克韦尔医疗公司获得多年透析协议；股票上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMTI":1},"content_text":"Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.\nAs per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.\nThe agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.\nLast week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.\nThis month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.\nThis installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.\nAlso, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.\nPrice Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.\nRead Next:\n\nAsia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept\n\nImage via Shutterstock.\nUp Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.\nGet the latest stock analysis from Benzinga?\n\nROCKWELL MEDICAL (RMTI): Free Stock Analysis Report\n\nThis article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com\n© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}